Up-regulation of P-TEFb by the MEK1-extracellular Signal-regulated Kinase Signaling Pathway Contributes to Stimulated Transcription Elongation of Immediate Early Genes in Neuroendocrine Cells

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2007 Dec 19

PMID 18086894

Citations 24

Authors

Toshitsugu Fujita

Stephan Ryser

Isabelle Piuz

Werner Schlegel

Affiliations

Soon will be listed here.

Abstract

The positive elongation factor P-TEFb appears to function as a crucial C-terminal-domain (CTD) kinase for RNA polymerase II (Pol II) transcribing immediate early genes (IEGs) in neuroendocrine GH4C1 cells. Chromatin immunoprecipitation indicated that in resting cells Pol II occupied the promoter-proximal regions of the c-fos and junB genes, together with the negative elongation factors DSIF and NELF. Thyrotropin-releasing hormone (TRH)-induced recruitment of positive transcription elongation factor b (P-TEFb) abolished the pausing of Pol II and enhanced phosphorylation of CTD serine 2, resulting in transcription elongation. In addition, P-TEFb was essential for splicing and 3'-end processing of IEG transcripts. Importantly, the MEK1-extracellular signal-regulated kinase (ERK) signaling pathway activated by TRH up-regulated nuclear CDK9 and CDK9/cyclinT1 dimers (i.e., P-TEFb), facilitating the recruitment of P-TEFb to c-fos and other IEGs. Thus, in addition to established gene transcription control via promoter response elements, the MEK1-ERK signaling pathway controls transcription elongation by Pol II via the up-regulation of nuclear CDK9 integrated into P-TEFb.

Citing Articles

Activity-assembled nBAF complex mediates rapid immediate early gene transcription by regulating RNA polymerase II productive elongation.

Cornejo K, Venegas A, Sono M, Door M, Gutierrez-Ruiz B, Karabedian L Cell Rep. 2024; 43(11):114877.

PMID: 39412992 PMC: 11625021. DOI: 10.1016/j.celrep.2024.114877.

Transcriptional activation of candidate paused genes after partial hepatectomy.

Mayeux F, Buisine N, Fayol O, Uguen P MicroPubl Biol. 2024; 2024.

PMID: 38919542 PMC: 11196992. DOI: 10.17912/micropub.biology.001160.

The Bidirectional Link Between RNA Cleavage and Polyadenylation and Genome Stability: Recent Insights From a Systematic Screen.

Spada S, Luke B, Danckwardt S Front Genet. 2022; 13:854907.

PMID: 35571036 PMC: 9095915. DOI: 10.3389/fgene.2022.854907.

Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition.

Lai L, Brel V, Sharma K, Frappier J, Le-Henanf N, Vivet B SLAS Discov. 2021; 26(7):922-932.

PMID: 33896272 PMC: 8791284. DOI: 10.1177/24725552211008853.

Transcriptional Enhancers in .

Small S, Arnosti D Genetics. 2020; 216(1):1-26.

PMID: 32878914 PMC: 7463283. DOI: 10.1534/genetics.120.301370.

References

Yamada T, Yamaguchi Y, Inukai N, Okamoto S, Mura T, Handa H . P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation. Mol Cell. 2006; 21(2):227-37. DOI: 10.1016/j.molcel.2005.11.024. View

Thompson N, Steinberg T, Aronson D, Burgess R . Inhibition of in vivo and in vitro transcription by monoclonal antibodies prepared against wheat germ RNA polymerase II that react with the heptapeptide repeat of eukaryotic RNA polymerase II. J Biol Chem. 1989; 264(19):11511-20. View

Buratowski S . The CTD code. Nat Struct Biol. 2003; 10(9):679-80. DOI: 10.1038/nsb0903-679. View

Ho C, Shuman S . Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol Cell. 1999; 3(3):405-11. DOI: 10.1016/s1097-2765(00)80468-2. View

Palangat M, Renner D, Price D, Landick R . A negative elongation factor for human RNA polymerase II inhibits the anti-arrest transcript-cleavage factor TFIIS. Proc Natl Acad Sci U S A. 2005; 102(42):15036-41. PMC: 1257689. DOI: 10.1073/pnas.0409405102. View

Kaplan C, Morris J, Wu C, Winston F . Spt5 and spt6 are associated with active transcription and have characteristics of general elongation factors in D. melanogaster. Genes Dev. 2000; 14(20):2623-34. PMC: 316994. DOI: 10.1101/gad.831900. View

Conaway J, Shilatifard A, Dvir A, Conaway R . Control of elongation by RNA polymerase II. Trends Biochem Sci. 2000; 25(8):375-80. DOI: 10.1016/s0968-0004(00)01615-7. View

Kiernan R, Emiliani S, Nakayama K, Castro A, Labbe J, Lorca T . Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol Cell Biol. 2001; 21(23):7956-70. PMC: 99964. DOI: 10.1128/MCB.21.23.7956-7970.2001. View

Krumm A, Meulia T, Groudine M . Common mechanisms for the control of eukaryotic transcriptional elongation. Bioessays. 1993; 15(10):659-65. DOI: 10.1002/bies.950151005. View

10.

Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, Sugimoto S . NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell. 1999; 97(1):41-51. DOI: 10.1016/s0092-8674(00)80713-8. View

11.

Kelemen B, Hsiao K, Goueli S . Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides. J Biol Chem. 2002; 277(10):8741-8. DOI: 10.1074/jbc.M108459200. View

12.

Yamaguchi Y, Wada T, Handa H . Interplay between positive and negative elongation factors: drawing a new view of DRB. Genes Cells. 1998; 3(1):9-15. DOI: 10.1046/j.1365-2443.1998.00162.x. View

13.

Zhou M, Halanski M, Radonovich M, Kashanchi F, Peng J, Price D . Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol Cell Biol. 2000; 20(14):5077-86. PMC: 85957. DOI: 10.1128/MCB.20.14.5077-5086.2000. View

14.

Jones J, Phatnani H, Haystead T, MacDonald J, Alam S, Greenleaf A . C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J Biol Chem. 2004; 279(24):24957-64. PMC: 2680323. DOI: 10.1074/jbc.M402218200. View

15.

Schroeder S, Schwer B, Shuman S, Bentley D . Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 2000; 14(19):2435-40. PMC: 316982. DOI: 10.1101/gad.836300. View

16.

Napolitano G, Licciardo P, Carbone R, Majello B, Lania L . CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization. J Cell Physiol. 2002; 192(2):209-15. DOI: 10.1002/jcp.10130. View

17.

Favata M, Horiuchi K, Manos E, Daulerio A, Stradley D, Feeser W . Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998; 273(29):18623-32. DOI: 10.1074/jbc.273.29.18623. View

18.

Pinaud S, Mirkovitch J . Regulation of c-fos expression by RNA polymerase elongation competence. J Mol Biol. 1998; 280(5):785-98. DOI: 10.1006/jmbi.1998.1905. View

19.

Chao S, Price D . Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo. J Biol Chem. 2001; 276(34):31793-9. DOI: 10.1074/jbc.M102306200. View

20.

Ryser S, Fujita T, Tortola S, Piuz I, Schlegel W . The rate of c-fos transcription in vivo is continuously regulated at the level of elongation by dynamic stimulus-coupled recruitment of positive transcription elongation factor b. J Biol Chem. 2006; 282(7):5075-5084. DOI: 10.1074/jbc.M607847200. View